- Home
- YQ vs LGVN Comparison
YQ vs LGVN Comparison
Compare YQ & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YQ
- LGVN
- Stock Information
- Founded
- YQ 2012
- LGVN 2014
- Country
- YQ China
- LGVN United States
- Employees
- YQ N/A
- LGVN N/A
- Industry
- YQ Other Consumer Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- YQ Real Estate
- LGVN Health Care
- Exchange
- YQ Nasdaq
- LGVN Nasdaq
- Market Cap
- YQ 19.4M
- LGVN 16.4M
- IPO Year
- YQ 2020
- LGVN 2021
- Fundamental
- Price
- YQ $3.02
- LGVN $0.76
- Analyst Decision
- YQ
- LGVN Strong Buy
- Analyst Count
- YQ 0
- LGVN 2
- Target Price
- YQ N/A
- LGVN $6.50
- AVG Volume (30 Days)
- YQ 22.6K
- LGVN 481.9K
- Earning Date
- YQ 09-03-2025
- LGVN 11-11-2025
- Dividend Yield
- YQ N/A
- LGVN N/A
- EPS Growth
- YQ N/A
- LGVN N/A
- EPS
- YQ N/A
- LGVN N/A
- Revenue
- YQ $20,003,071.00
- LGVN $2,073,000.00
- Revenue This Year
- YQ N/A
- LGVN N/A
- Revenue Next Year
- YQ N/A
- LGVN N/A
- P/E Ratio
- YQ N/A
- LGVN N/A
- Revenue Growth
- YQ N/A
- LGVN 68.67
- 52 Week Low
- YQ $1.26
- LGVN $0.63
- 52 Week High
- YQ $3.19
- LGVN $2.48
- Technical
- Relative Strength Index (RSI)
- YQ 77.65
- LGVN 35.86
- Support Level
- YQ $2.10
- LGVN $0.78
- Resistance Level
- YQ $2.81
- LGVN $0.85
- Average True Range (ATR)
- YQ 0.18
- LGVN 0.05
- MACD
- YQ 0.09
- LGVN 0.02
- Stochastic Oscillator
- YQ 98.24
- LGVN 25.68
About YQ 17 Education & Technology Group Inc.
17 Education & Technology Group Inc is an education technology company in China. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.